Antimicrobial Strategies against Oral Pathogenic Bacteria and Biofilm—2nd Volume

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiofilm Strategies".

Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 1701

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medicine, Faculty of Medicine, University Complutense of Madrid, Madrid, Spain
Interests: microbiology; bacterial biofilms; oral pathogens; genomics; metabolomics; cell biology; development of new antimicrobial agents; mechanisms of antibiotic resistance
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue is a continuation of our previous Special Issue on the same topic entitled Oral Pathogenic Bacteria Infection Control

In the oral cavity, microbial homeostasis and its maintenance represent a great global challenge. Microorganisms in this niche are organized in groups of multiple species, that is, in biofilms. Nowadays, the characterization of the species diversity of these communities is advancing rapidly through next-generation sequencing; however, we must not forget their functionality, knowledge that advances more slowly with regard to their metabolic properties and the flows of substrates and products, which increasingly reveal microbial taxa of unknown but key functions in the development of oral disease. The alteration of the balance in the oral cavity, and, therefore, the dysbiosis of the microbial community present in its different locations, constitute an important factor in determining the virulence of the microbial consortium and the consequent development of oral infectious diseases, including dental caries, gingivitis, periodontitis, endodontic periapical lesions, and peri-implantitis.

The effective management of oral infectious diseases related to biofilms is a challenge with multiple approaches that must continue to develop, ranging from the precise and continuous elimination of specific oral pathogens to the use of antimicrobial agent release, contact-killing, and multi-functional strategies for the prevention of initial bacterial attachment or biofilm dispersal. Much remains to be investigated about the reasons for the emergence of specific organisms, changes in relative abundances, their interdependence between species, their fitness or their adaptations related to oral diseases. Likewise, the use of probiotics and compounds that modulate the virulence of the oral biofilm without killing commensal bacteria and the application of novel approaches such as nanomaterials, quaternary ammonium salts, arginine or natural products, avoiding the elimination of commensals that can cause ecological dysbiosis, are presented as powerful preventive tools. Antimicrobial photodynamic therapy or cold atmospheric plasma application has also emerged as an alternative to antimicrobial treatments and biofilm disruption.

This Special Issue aims to gather papers describing innovative antimicrobial strategies with the potential to control infections related to oral biofilms with special interest in those capable of inhibiting biofilm virulence without necessarily inducing the microbial dysbiosis of oral biofilms. Also, papers are requested to improve our knowledge of the metabolic properties and the fluxes of substrates and products that occur in these oral microbial communities related to the development of the diseases. These methods can be used in the near future to effectively promote the clinical management of infectious oral diseases, and thus benefit oral health in the face of the increasing emergence of antibiotic-resistant bacteria.

After the successful first volume on Oral Pathogenic Bacteria Infection Control, and considering the great challenges that these infections entail, we are delighted to launch a second volume, in which we hope to bring together the new advances in this exciting topic. We kindly invite you to submit original research articles as well as review articles.

Prof. Dr. María C. Sánchez Beltrán
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oral biofilms
  • oral pathogenic bacteria
  • oral infections
  • antimicrobial strategies
  • microbial oral homeostasis
  • oral dysbiosis
  • antibiotic resistance

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 4279 KiB  
Article
Profiling Antibiotic Susceptibility among Distinct Enterococcus faecalis Isolates from Dental Root Canals
by Daniel Manoil, Ender Efe Cerit, Hong Fang, Stéphane Durual, Malin Brundin and Georgios N. Belibasakis
Antibiotics 2024, 13(1), 18; https://doi.org/10.3390/antibiotics13010018 - 24 Dec 2023
Cited by 1 | Viewed by 1537
Abstract
Enterococcus faecalis, a leading multi-resistant nosocomial pathogen, is also the most frequently retrieved species from persistently infected dental root canals, suggesting that the oral cavity is a possible reservoir for resistant strains. However, antimicrobial susceptibility testing (AST) for oral enterococci remains scarce. [...] Read more.
Enterococcus faecalis, a leading multi-resistant nosocomial pathogen, is also the most frequently retrieved species from persistently infected dental root canals, suggesting that the oral cavity is a possible reservoir for resistant strains. However, antimicrobial susceptibility testing (AST) for oral enterococci remains scarce. Here, we examined the AST profiles of 37 E. faecalis strains, including thirty-four endodontic isolates, two vanA-type vancomycin-resistant isolates, and the reference strain ATCC-29212. Using Etest gradient strips and established EUCAST standards, we determined minimum inhibitory concentrations (MICs) for amoxicillin, vancomycin, clindamycin, tigecycline, linezolid, and daptomycin. Results revealed that most endodontic isolates were susceptible to amoxicillin and vancomycin, with varying levels of intrinsic resistance to clindamycin. Isolates exceeding the clindamycin MIC of the ATCC-29212 strain were further tested against last-resort antibiotics, with 7/27 exhibiting MICs matching the susceptibility breakpoint for tigecycline, and 1/27 reaching that of linezolid. Both vanA isolates confirmed vancomycin resistance and demonstrated resistance to tigecycline. In conclusion, while most endodontic isolates remained susceptible to first-line antibiotics, several displayed marked intrinsic clindamycin resistance, and MICs matched tigecycline’s breakpoint. The discovery of tigecycline resistance in vanA isolates highlights the propensity of clinical clone clusters to acquire multidrug resistance. Our results emphasize the importance of implementing AST strategies in dental practices for continued resistance surveillance. Full article
Show Figures

Figure 1

Back to TopTop